Showing results (61-70 of 366) with videos related to

Sort By:
Pageof 37
Breast Cancer Research : BCR|April 16, 2004
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?Kathy D Miller
Breast Cancer Research and Treatment|October 2, 2002
Issues and challenges for antiangiogenic therapiesKathy D Miller
The Oncologist|May 28, 2004
The role of ErbB inhibitors in trastuzumab resistanceKathy D Miller
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agentsXiangshu Fei, Qi Huang Zheng, Xuan Liu, et al.
JCO Precision Oncology|January 16, 2018
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103Bryan P Schneider, Fei Shen, Guanglong Jiang, et al.
Cancer Medicine|December 2, 2020
Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancerSamilia Obeng-Gyasi, Anne O'Neill, Fengmin Zhao, et al.
Nature Reviews. Clinical Oncology|January 21, 2021
Liquid biopsy enters the clinic - implementation issues and future challengesMichail Ignatiadis, George W Sledge, Stefanie S Jeffrey
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
CancerLinQ and the future of cancer careGeorge W Sledge, Robert S Miller, Robert Hauser
Nuclear Medicine and Biology|November 28, 2002
[11C]Choline as a potential PET marker for imaging of breast cancer athymic miceQi-Huang Zheng, K Lee Stone, Bruce H Mock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancerKathy D Miller, Thomas J Saphner, David M Waterhouse, et al.
Pageof 37